The complete response (CR) rate at 1 month improved from 25% with single-fraction conformal 3D RT (3D-CRT) to 37% with SBRT, ...

The Trump administration is already gearing up for another round of Medicare drug price negotiations, while OpenAI launched a ...

Exelixis delivers a strong Q1 performance with raised 2025 guidance, robust Cabometyx sales, and share buybacks. Read the ...

Revisions to classification criteria ‘will ensure homogeneous trial populations’ with data-driven scoring, a standardized MRI ...

The risk calculator shows improved precision in a population larger than the original dataset used to validate the tool.

Las acciones de las empresas farmacéuticas cayeron en todo el mundo después de que el presidente de EE.UU., Donald Trump, ...

Shares of Bristol Myers Squibb Co. BMY slipped 1.55% to $46.88 Thursday, on what proved to be an all-around positive trading ...

Hawaii will receive $700 million from pharmaceutical giants Bristol Myers Squibb and Sanofi in a landmark settlement over the ...

Bristol Myers Squibb (BMY) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at ...

We recently published a list of Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now. In this article, we are ...

Bristol-Myers Squibb is undervalued with a 5%+ dividend yield, robust pipeline, and recession-resistant business. Click here to find out why BMY stock is a Buy.

My shift schedule allowed me to allocate time to complete my third-level education - a biopharmaceutical processing degree at ...